Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update
Authors:
- Edoardo SpinaESEdoardo Spina
- Vincenza SantoroVSVincenza Santoro
- Concetta D'ARrigoCDConcetta D'ARrigo
Top Cited Papers
- 1 July 2008
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 30 (7) , 1206-1227
Abstract
No abstract availableKeywords
This publication has 163 references indexed in Scilit:
- Increased use of antidepressants at the end of life: population-based study among people aged 65 years and aboveAge and Ageing, 2007
- Detrimental Antidepressant Drug–Drug Interactions: Are They Clinically Relevant?Neuropsychopharmacology, 2006
- Antidepressant–Drug Interactions are Potentially but Rarely Clinically SignificantNeuropsychopharmacology, 2006
- Coadministration of scrtraline with cisapride or pimozide: an open-label, nonrandomized examination of pharmacokinetics and corrected qt intervals in healthy adult volunteersClinical Therapeutics, 2005
- Fluoxetine augmentation in citalopram non-responders: pharmacokinetic and clinical consequencesInternational Journal of Neuropsychopharmacology, 2000
- Co-administration of citalopram and clozapineInternational Clinical Psychopharmacology, 1998
- Pharmacokinetic and Pharmacodynamic Evaluation of the Potential Drug Interaction Between Venlafaxine and DiazepamThe Journal of Clinical Pharmacology, 1995
- Heart block in a patient on propranolol and fluoxetineThe Lancet, 1994
- Interaction of metoprolol and fluoxetineThe Lancet, 1993
- Fluoxetine‐Induced Tricyclic Toxicity: Extent and DurationThe Journal of Clinical Pharmacology, 1991